Moody National Bank Trust Division’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-922
Closed -$403K – 573
2023
Q3
$403K Hold
922
– – 0.03% 438
2023
Q2
$463K Hold
922
– – 0.03% 398
2023
Q1
$461K Hold
922
– – 0.04% 388
2022
Q4
$376K Buy
922
+34
+4% +$13.2K 0.03% 426
2022
Q3
$289K Hold
888
– – 0.03% 480
2022
Q2
$311K Buy
+888
New +$362K 0.03% 396
2022
Q1
– Sell
-346
Closed -$228K – 375
2021
Q4
$228K Hold
346
– – 0.01% 348
2021
Q3
$215K Hold
346
– – ﹤0.01% 394
2021
Q2
$219K Buy
+346
New +$191K ﹤0.01% 389
2019
Q2
– Sell
-96
Closed -$21K – 653
2019
Q1
$21K Buy
96
+23
+32% +$4.75K ﹤0.01% 539
2018
Q4
$14K Buy
+73
New +$15K ﹤0.01% 543

Other funds holding IDXX

Moody National Bank Trust Division's IDXX Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 922 shares — an estimated $403K sold.

Moody National Bank Trust Division first reported a position in IDXX in Q4 2018 and held it in 11 quarters. The position peaked at $463K in Q2 2023. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Moody National Bank Trust Division reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 922 Idexx Laboratories shares in Q4 2023, an estimated $403K.
  • Moody National Bank Trust Division first reported a position in Idexx Laboratories in Q4 2018 and held it in 11 quarters.
  • Moody National Bank Trust Division's Idexx Laboratories position peaked at $463K in Q2 2023.
  • 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.